David C. Uprichard

David C. Uprichard discloses dealings in 3 companies, chiefly Invitrogen Corp, Bio Green Med Solution, Inc. and Alpharma Inc. Over a trading history stretching from 27 March 2006 to 3 February 2014, the count stands at 168 filings.

Both buying and selling appear: 17 purchases worth €62k, against 104 sales worth €2.2M. Sales outweigh purchases by €2.1M. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 44 option exercises.

The median purchase comes to €3,276.

The newest entry dates from 4 February 2014: a transaction of €165k, in Invitrogen Corp. The most recent open-market purchase was published on 13 June 2008, 6,706 days ago. The median gap between a trade and its publication by SEC (Form 4) is 1 day. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.